echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > The Production Process of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester

    The Production Process of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester

    • Last Update: 2023-05-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The Production Process of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester: An Overview in the Chemical Industry


    4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester, also known as MAPK inhibitor GSK2118436A or 4-Cl-IOZD-Py, is a selective inhibitor of the p38 mitogen-activated protein kinase (MAPK) pathway.
    In recent years, there has been significant interest in the development of MAPK inhibitors as potential therapeutic agents for various diseases, including cancer, inflammatory diseases, and cardiovascular diseases.
    As a result, the production process of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester has gained significant attention in the chemical industry.


    In this article, we will provide an overview of the production process of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester, highlighting the key steps involved in the production of this compound.


    Step 1: Synthesis of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid
    The synthesis of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid, also known as the starting material, is the first step in the production process of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester.
    The synthesis of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid can be achieved through various methods, such as the reaction of 5-ethyl-2,4-diamino-6-oxo-1,2,4-trioxaborinazine with sodium hydride in acetic acid, followed by treatment with chloroform and hydrochloric acid.


    Step 2: Esterification of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid with ethyl alcohol
    The next step in the production process of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester is the esterification of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid with ethyl alcohol.
    This reaction can be carried out in the presence of a catalyst such as trifluoroacetic acid (TFA) or 1,1,1-trifluoro-2-propanamide.
    The reaction is typically carried out at a temperature of 0°C to 5°C, and the final product is isolated by precipitation with a suitable solvent, such as diethyl ether.


    Step 3: Purification of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester
    The purification of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester is a critical step in the production process, as it ensures the quality and purity of the final product.
    There are several methods that can be used for the purification of 4-Chloroisoxazolo[5,4-d]pyrimidine-3-carboxylic acid ethyl ester, such as crystallization, silica gel chromatography, and high


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.